Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management.
Sato R, Hasegawa D, Guo S, Nuqali AE, Moreno JEP.
J Intensive Care. 2025 Jan 2;13(1):1. doi: 10.1186/s40560-024-00770-y.
Sepsis-Induced Cardiomyopathy: Mechanism, Prevalence, Assessment, Prognosis, and Management.
Sato R, Sanfilippo F, Lanspa M, Duggal A, Dugar S.
Chest. 2025 Dec;168(6):1383-1394. doi: 10.1016/j.chest.2025.08.013. Epub 2025 Sep 3.
Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?
Asfar P.
Intensive Care Med. 2003 Feb;29(2):154-5. doi: 10.1007/s00134-002-1590-1.
[Hyperdynamic or hyperkinetic shock].
Ciesielski L.
Pol Przegl Chir. 1972 Jul;44(7):1277-83.
Septic shock.
Goodwin JK, Schaer M.
Vet Clin North Am Small Anim Pract. 1989 Nov;19(6):1239-58. doi: 10.1016/s0195-5616(89)50137-2.
[Beta-blockers in Septic Shock].
Uhlig C, Spieth PM.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Nov;53(11-12):787-792. doi: 10.1055/s-0043-124906. Epub 2018 Nov 20.
Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock.
Nguyen NTQ, Doan TNM, Sato K, Tkaczyk C, Sellman BR, Diep BA.
Front Immunol. 2023 Sep 15;14:1260627. doi: 10.3389/fimmu.2023.1260627. eCollection 2023.
Similar Microcirculatory Alterations in Patients with Normodynamic and Hyperdynamic Septic Shock.
Edul VS, Ince C, Vazquez AR, Rubatto PN, Espinoza ED, Welsh S, Enrico C, Dubin A.
Ann Am Thorac Soc. 2016 Feb;13(2):240-7. doi: 10.1513/AnnalsATS.201509-606OC.
Cirrhotic Multiorgan Syndrome.
Møller S, Bendtsen F.
Dig Dis Sci. 2015 Nov;60(11):3209-25. doi: 10.1007/s10620-015-3752-3. Epub 2015 Jun 26.
Revisiting septic shock in cirrhosis: a call for personalized management.
Girish V, Maiwall R.
Expert Rev Gastroenterol Hepatol. 2024 Dec;18(12):795-813. doi: 10.1080/17474124.2024.2443813. Epub 2025 Jan 2.
